Pieris napi chromosome 23, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997717.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
translational regulator orb2, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
cytoplasmic polyadenylation element-binding protein 2 isoform X1
translational regulator orb2, transcript variant X2
U6 snRNA-associated Sm-like protein LSm4
guanine nucleotide-binding protein-like 1, transcript variant X1
guanine nucleotide-binding protein-like 1, transcript variant X2
guanine nucleotide-binding protein-like 1
cytotoxic granule associated RNA binding protein TIA1, transcript variant X1
cytotoxic granule associated RNA binding protein TIA1, transcript variant X2
cytotoxic granule associated RNA binding protein TIA1, transcript variant X3
cytotoxic granule associated RNA binding protein TIA1 isoform X3
serine protease Hayan-like, transcript variant X1
serine protease Hayan-like, transcript variant X2
esterase FE4-like, transcript variant X1
esterase FE4-like, transcript variant X2
juvenile hormone esterase-like isoform X1
uncharacterized LOC125061357, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125061357, transcript variant X2
uncharacterized LOC125061357, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
zinc finger and BTB domain-containing protein 11-like
4-hydroxybenzoate polyprenyltransferase, mitochondrial
zinc finger protein 91-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GTP-binding protein 2-like, transcript variant X1
GTP-binding protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X7
zinc finger protein 91-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein 91-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
acetylcholinesterase-like, transcript variant X2
acetylcholinesterase-like, transcript variant X4
acetylcholinesterase-like, transcript variant X1
acetylcholinesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
mitochondrial ribosome-associated GTPase 2
zinc finger and SCAN domain-containing protein 12-like, transcript variant X2
zinc finger and SCAN domain-containing protein 12-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 118 samples with support for all annotated introns
zinc finger and SCAN domain-containing protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
RNA pseudouridylate synthase domain-containing protein 1-like
eukaryotic translation initiation factor 5B
U1 small nuclear ribonucleoprotein 70 kDa
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine-protein kinase ULK3-like, transcript variant X1
serine/threonine-protein kinase ULK3-like isoform X1
serine/threonine-protein kinase ULK3-like, transcript variant X2
serine/threonine-protein kinase ULK3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
adenylyltransferase and sulfurtransferase MOCS3
uncharacterized LOC125061156, transcript variant X1
uncharacterized LOC125061156, transcript variant X2
uncharacterized LOC125061150, transcript variant X1
uncharacterized LOC125061150, transcript variant X2
uncharacterized LOC125061152, transcript variant X3
uncharacterized LOC125061152, transcript variant X1
uncharacterized LOC125061152, transcript variant X2
RNA exonuclease 4-like, transcript variant X3
RNA exonuclease 4-like, transcript variant X1
RNA exonuclease 4-like, transcript variant X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X3
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X4
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
UDP-N-acetylhexosamine pyrophosphorylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 108 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X4
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
EEF1A lysine methyltransferase 2, transcript variant X3
EEF1A lysine methyltransferase 2, transcript variant X1
EEF1A lysine methyltransferase 2, transcript variant X2
motile sperm domain-containing protein 2-like
adenosine 5'-monophosphoramidase HINT3-like
pneumococcal serine-rich repeat protein-like
gamete and mating-type specific protein A-like, transcript variant X1
gamete and mating-type specific protein A-like, transcript variant X2
gamete and mating-type specific protein A-like isoform X1
gamete and mating-type specific protein A-like isoform X2
protein Fer3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
protein Fer3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized protein LOC125061447 isoform X2
nuclear pore complex protein Nup98-Nup96, transcript variant X3
nuclear pore complex protein Nup98-Nup96, transcript variant X2
nuclear pore complex protein Nup98-Nup96, transcript variant X1
nuclear pore complex protein Nup98-Nup96 isoform X3
nuclear pore complex protein Nup98-Nup96 isoform X2
nuclear pore complex protein Nup98-Nup96 isoform X1
uncharacterized LOC125061403, transcript variant X3
uncharacterized LOC125061403, transcript variant X2
uncharacterized LOC125061403, transcript variant X1
uncharacterized protein LOC125061403 isoform X3
uncharacterized protein LOC125061403 isoform X2
uncharacterized protein LOC125061403 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
UPF0547 protein C16orf87 homolog, transcript variant X1
UPF0547 protein C16orf87 homolog, transcript variant X2
UPF0547 protein C16orf87 homolog isoform X1
UPF0547 protein C16orf87 homolog isoform X2
spermine oxidase-like, transcript variant X1
spermine oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 153 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 101 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
cleavage and polyadenylation specificity factor subunit 5
protein SpAN-like, transcript variant X1
uncharacterized protein LOC125061483 isoform X1
protein SpAN-like, transcript variant X2
uncharacterized LOC125061595, transcript variant X1
uncharacterized LOC125061595, transcript variant X4
uncharacterized LOC125061595, transcript variant X3
uncharacterized LOC125061595, transcript variant X2
leishmanolysin-like peptidase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 137 samples with support for all annotated introns
leishmanolysin-like peptidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
leishmanolysin-like peptidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
leishmanolysin-like peptidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
leishmanolysin-like peptidase isoform X4
leishmanolysin-like peptidase isoform X2
leishmanolysin-like peptidase isoform X3
leishmanolysin-like peptidase isoform X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
uncharacterized LOC125061497, transcript variant X1
uncharacterized protein LOC125061497 isoform X1
uncharacterized LOC125061497, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC125061497 isoform X2
myosin tail region-interacting protein MTI1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
thyrotropin-releasing hormone-degrading ectoenzyme, transcript variant X1
thyrotropin-releasing hormone-degrading ectoenzyme, transcript variant X2
thyrotropin-releasing hormone-degrading ectoenzyme isoform X1
thyrotropin-releasing hormone-degrading ectoenzyme isoform X2
oxysterol-binding protein-related protein 8, transcript variant X1
oxysterol-binding protein-related protein 8, transcript variant X3
oxysterol-binding protein-related protein 8, transcript variant X2
oxysterol-binding protein-related protein 8 isoform X3
oxysterol-binding protein-related protein 8 isoform X2
oxysterol-binding protein-related protein 8 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger protein 23-like, transcript variant X1
zinc finger protein 23-like, transcript variant X2
zinc finger protein 23-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
glycosyltransferase-like protein gnt13 isoform X3
28S ribosomal protein S35, mitochondrial
uncharacterized LOC125061092, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X4
uncharacterized LOC125061092, transcript variant X3
uncharacterized LOC125061092, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X11
uncharacterized LOC125061092, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC125061092, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 142 samples with support for all annotated introns
uncharacterized protein LOC125061092 isoform X3
uncharacterized protein LOC125061092 isoform X2
uncharacterized protein LOC125061092 isoform X6
uncharacterized protein LOC125061092 isoform X8
uncharacterized protein LOC125061092 isoform X7
uncharacterized protein LOC125061092 isoform X4
uncharacterized protein LOC125061092 isoform X5
uncharacterized protein LOC125061092 isoform X9
uncharacterized protein LOC125061092 isoform X10
uncharacterized protein LOC125061092 isoform X1
uncharacterized LOC125061088, transcript variant X16
uncharacterized LOC125061088, transcript variant X7
uncharacterized LOC125061088, transcript variant X5
uncharacterized LOC125061088, transcript variant X25
uncharacterized LOC125061088, transcript variant X9
uncharacterized LOC125061088, transcript variant X12
uncharacterized LOC125061088, transcript variant X26
uncharacterized LOC125061088, transcript variant X18
uncharacterized LOC125061088, transcript variant X6
uncharacterized protein LOC125061088 isoform X6
uncharacterized protein LOC125061088 isoform X5
uncharacterized protein LOC125061088 isoform X18
uncharacterized protein LOC125061088 isoform X8
uncharacterized protein LOC125061088 isoform X10
uncharacterized protein LOC125061088 isoform X19
uncharacterized protein LOC125061088 isoform X12
uncharacterized LOC125061088, transcript variant X24
uncharacterized protein LOC125061088 isoform X17
uncharacterized LOC125061088, transcript variant X27
uncharacterized protein LOC125061088 isoform X20
uncharacterized LOC125061088, transcript variant X36
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
uncharacterized LOC125061088, transcript variant X37
uncharacterized LOC125061088, transcript variant X38
uncharacterized LOC125061088, transcript variant X31
uncharacterized LOC125061088, transcript variant X42
uncharacterized LOC125061088, transcript variant X33
uncharacterized LOC125061088, transcript variant X35
uncharacterized LOC125061088, transcript variant X32
uncharacterized LOC125061088, transcript variant X34
uncharacterized LOC125061088, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
uncharacterized LOC125061088, transcript variant X39
uncharacterized LOC125061088, transcript variant X28
uncharacterized LOC125061088, transcript variant X29
uncharacterized LOC125061088, transcript variant X30
uncharacterized LOC125061088, transcript variant X46
uncharacterized LOC125061088, transcript variant X45
uncharacterized LOC125061088, transcript variant X41
uncharacterized LOC125061088, transcript variant X4
uncharacterized LOC125061088, transcript variant X3
uncharacterized LOC125061088, transcript variant X1
uncharacterized LOC125061088, transcript variant X2
uncharacterized LOC125061088, transcript variant X10
uncharacterized LOC125061088, transcript variant X43
uncharacterized LOC125061088, transcript variant X11
uncharacterized LOC125061088, transcript variant X17
uncharacterized LOC125061088, transcript variant X15
uncharacterized protein LOC125061088 isoform X29
uncharacterized protein LOC125061088 isoform X30
uncharacterized protein LOC125061088 isoform X31
uncharacterized protein LOC125061088 isoform X35
uncharacterized protein LOC125061088 isoform X26
uncharacterized protein LOC125061088 isoform X28
uncharacterized protein LOC125061088 isoform X24
uncharacterized protein LOC125061088 isoform X25
uncharacterized protein LOC125061088 isoform X27
uncharacterized protein LOC125061088 isoform X7
uncharacterized protein LOC125061088 isoform X32
uncharacterized protein LOC125061088 isoform X34
uncharacterized protein LOC125061088 isoform X21
uncharacterized protein LOC125061088 isoform X22
uncharacterized protein LOC125061088 isoform X23
uncharacterized protein LOC125061088 isoform X39
uncharacterized protein LOC125061088 isoform X38
uncharacterized protein LOC125061088 isoform X4
uncharacterized protein LOC125061088 isoform X3
uncharacterized protein LOC125061088 isoform X1
uncharacterized protein LOC125061088 isoform X2
uncharacterized protein LOC125061088 isoform X9
uncharacterized protein LOC125061088 isoform X36
uncharacterized LOC125061088, transcript variant X19
uncharacterized protein LOC125061088 isoform X13
uncharacterized LOC125061088, transcript variant X21
uncharacterized protein LOC125061088 isoform X15
uncharacterized LOC125061088, transcript variant X20
uncharacterized LOC125061088, transcript variant X22
uncharacterized LOC125061088, transcript variant X13
uncharacterized LOC125061088, transcript variant X23
uncharacterized LOC125061088, transcript variant X14
uncharacterized protein LOC125061088 isoform X11
uncharacterized protein LOC125061088 isoform X14
uncharacterized protein LOC125061088 isoform X16
uncharacterized LOC125061088, transcript variant X50
uncharacterized protein LOC125061088 isoform X41
uncharacterized LOC125061097, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X5
uncharacterized LOC125061097, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
uncharacterized LOC125061097, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
uncharacterized protein LOC125061097 isoform X2
uncharacterized protein LOC125061097 isoform X1
uncharacterized protein LOC125061097 isoform X4
uncharacterized protein LOC125061097 isoform X3
uncharacterized protein LOC125061097 isoform X5
uncharacterized protein LOC125061097 isoform X6
uncharacterized LOC125061088, transcript variant X40
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
uncharacterized protein LOC125061088 isoform X33
uncharacterized LOC125061088, transcript variant X47
uncharacterized LOC125061088, transcript variant X49
uncharacterized LOC125061088, transcript variant X44
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC125061088, transcript variant X48
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
uncharacterized protein LOC125061088 isoform X37
uncharacterized protein LOC125061088 isoform X40
la-related protein 1, transcript variant X3
la-related protein 1, transcript variant X2
la-related protein 1, transcript variant X1
la-related protein 1, transcript variant X4
uncharacterized LOC125061107, transcript variant X2
uncharacterized LOC125061107, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized protein LOC125061107 isoform X2
uncharacterized protein LOC125061107 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
monocarboxylate transporter 13-like, transcript variant X1
monocarboxylate transporter 13-like isoform X1
monocarboxylate transporter 13-like, transcript variant X2
monocarboxylate transporter 13-like isoform X2
uncharacterized LOC125061095, transcript variant X2
uncharacterized LOC125061095, transcript variant X3
uncharacterized LOC125061095, transcript variant X1
uncharacterized protein LOC125061095 isoform X3
uncharacterized protein LOC125061095 isoform X1
uncharacterized protein LOC125061095 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cell wall protein IFF6-like, transcript variant X11
cell wall protein IFF6-like, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 160 samples with support for all annotated introns
cell wall protein IFF6-like, transcript variant X9
cell wall protein IFF6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
cell wall protein IFF6-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ESX-1 secretion-associated protein EspK-like isoform X9
cell wall protein IFF6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
cell wall protein IFF6-like, transcript variant X8
ESX-1 secretion-associated protein EspK-like isoform X8
cell wall protein IFF6-like, transcript variant X13
cell wall protein IFF6-like, transcript variant X10
cell wall protein IFF6-like, transcript variant X4
cell wall protein IFF6-like, transcript variant X12
cell wall protein IFF6-like, transcript variant X14
cell wall protein IFF6-like, transcript variant X17
cell wall protein IFF6-like, transcript variant X6
cell wall protein IFF6-like, transcript variant X15
cell wall protein IFF6-like, transcript variant X7
cell wall protein IFF6-like, transcript variant X1
hyphally regulated cell wall protein 1-like isoform X7
cell wall protein IFF6-like, transcript variant X16
cysteine-rich and transmembrane domain-containing protein WIH2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125061127, transcript variant X2
uncharacterized LOC125061127, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
putative per-hexamer repeat protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
putative per-hexamer repeat protein 5 isoform X2
putative per-hexamer repeat protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
putative per-hexamer repeat protein 5, transcript variant X4
putative per-hexamer repeat protein 5, transcript variant X5
putative per-hexamer repeat protein 5 isoform X5
putative per-hexamer repeat protein 5 isoform X4
putative per-hexamer repeat protein 5 isoform X3
putative per-hexamer repeat protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
putative per-hexamer repeat protein 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized LOC125061181, transcript variant X2
uncharacterized LOC125061181, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 139 samples with support for all annotated introns
segmentation protein cap'n'collar-like, transcript variant X9
segmentation protein cap'n'collar-like, transcript variant X3
segmentation protein cap'n'collar-like, transcript variant X4
segmentation protein cap'n'collar-like, transcript variant X8
segmentation protein cap'n'collar-like, transcript variant X1
segmentation protein cap'n'collar-like, transcript variant X2
segmentation protein cap'n'collar-like, transcript variant X7
segmentation protein cap'n'collar-like, transcript variant X6
segmentation protein cap'n'collar-like, transcript variant X5
segmentation protein cap'n'collar-like isoform X3
segmentation protein cap'n'collar-like isoform X2
segmentation protein cap'n'collar-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125061397, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
uncharacterized LOC125061397, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125061397, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC125061397 isoform X3
uncharacterized protein LOC125061397 isoform X4
uncharacterized protein LOC125061397 isoform X1
uncharacterized LOC125061397, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized protein LOC125061397 isoform X2
actin depolymerising venom protein gelsolin 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 151 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
cholesterol 7-desaturase nvd, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cholesterol 7-desaturase nvd, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
multiple coagulation factor deficiency protein 2 homolog, transcript variant X1
multiple coagulation factor deficiency protein 2 homolog, transcript variant X2
multiple coagulation factor deficiency protein 2 homolog
inactive peptidyl-prolyl cis-trans isomerase shutdown-like, transcript variant X3
inactive peptidyl-prolyl cis-trans isomerase shutdown-like, transcript variant X1
inactive peptidyl-prolyl cis-trans isomerase shutdown-like, transcript variant X2
inactive peptidyl-prolyl cis-trans isomerase shutdown-like
uncharacterized LOC125061323, transcript variant X8
uncharacterized LOC125061323, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC125061323, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC125061323, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125061323, transcript variant X7
uncharacterized LOC125061323, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125061323, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized LOC125061323, transcript variant X10
uncharacterized LOC125061323, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125061323, transcript variant X9
uncharacterized protein LOC125061323 isoform X3
uncharacterized protein LOC125061323 isoform X1
uncharacterized protein LOC125061323 isoform X2
uncharacterized LOC125061333, transcript variant X2
uncharacterized LOC125061333, transcript variant X1
prion-like-(Q/N-rich) domain-bearing protein 25
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine protease snake-like, transcript variant X2
serine protease snake-like, transcript variant X1
tubulin beta chain-like, transcript variant X1
tubulin beta chain-like, transcript variant X4
tubulin beta chain-like, transcript variant X2
tubulin beta chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
zinc finger protein 879-like, transcript variant X2
zinc finger protein 879-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
gastrula zinc finger protein XlCGF49.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase PRDM7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
signal transducer and activator of transcription 5B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X12
signal transducer and activator of transcription 5B, transcript variant X10
signal transducer and activator of transcription 5B, transcript variant X8
signal transducer and activator of transcription 5B, transcript variant X13
signal transducer and activator of transcription 5B, transcript variant X11
signal transducer and activator of transcription 5B, transcript variant X9
signal transducer and activator of transcription 5B, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X15
signal transducer and activator of transcription 5B, transcript variant X16
signal transducer and activator of transcription 5B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
signal transducer and activator of transcription 5B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
signal transducer and activator of transcription 5B isoform X3
signal transducer and activator of transcription 5B isoform X7
signal transducer and activator of transcription 5B isoform X4
signal transducer and activator of transcription 5B isoform X5
signal transducer and activator of transcription 5B isoform X8
signal transducer and activator of transcription 5B isoform X6
signal transducer and activator of transcription 5B isoform X9
signal transducer and activator of transcription 5B isoform X10
signal transducer and activator of transcription 5B isoform X11
signal transducer and activator of transcription 5B isoform X1
signal transducer and activator of transcription 5B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 149 samples with support for all annotated introns
uncharacterized LOC125061625, transcript variant X1
uncharacterized LOC125061625, transcript variant X2
dynamin-1-like protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
dynamin-1-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
dynamin-1-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
dynamin-1-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
dynamin-1-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns
dynamin-1-like protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
dynamin-1-like protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
dynamin-1-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
circadian clock-controlled protein daywake-like
TWiK family of potassium channels protein 9
cAMP-dependent protein kinase catalytic subunit alpha-like
cAMP-dependent protein kinase catalytic subunit beta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cytochrome P450 4g15, transcript variant X1
cytochrome P450 4g15, transcript variant X2
transcriptional regulator ovo-like, transcript variant X1
transcriptional regulator ovo-like, transcript variant X2
transcriptional regulator ovo-like isoform X1
transcriptional regulator ovo-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 116 samples with support for all annotated introns
zinc finger protein 28 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
zinc finger protein 28 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 134 samples with support for all annotated introns
zinc finger protein 28 homolog isoform X3
zinc finger protein 28 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
muscle M-line assembly protein unc-89-like, transcript variant X1
muscle M-line assembly protein unc-89-like, transcript variant X3
muscle M-line assembly protein unc-89-like, transcript variant X2
muscle M-line assembly protein unc-89-like isoform X2
fibrous sheath CABYR-binding protein-like isoform X1
muscle M-line assembly protein unc-89-like isoform X3
DNA-directed RNA polymerase I subunit rpa49-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
lysosomal alpha-mannosidase-like, transcript variant X3
lysosomal alpha-mannosidase-like, transcript variant X2
lysosomal alpha-mannosidase-like, transcript variant X1
lysosomal alpha-mannosidase-like isoform X1
lysosomal alpha-mannosidase-like isoform X2
lysosomal alpha-mannosidase-like isoform X3
S-phase kinase-associated protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
S-phase kinase-associated protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 90 samples with support for all annotated introns
S-phase kinase-associated protein 2 isoform X2
S-phase kinase-associated protein 2 isoform X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 isoform X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3, transcript variant X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3, transcript variant X3
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 isoform X1
intersectin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
intersectin-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 152 samples with support for all annotated introns
uncharacterized LOC125061436, transcript variant X2
uncharacterized LOC125061436, transcript variant X1
uncharacterized protein LOC125061436 isoform X1
uncharacterized protein LOC125061436 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
ubiquitin-related modifier 1 homolog, transcript variant X2
ubiquitin-related modifier 1 homolog, transcript variant X1
igLON family member 5, transcript variant X1
leucine-rich repeat extensin-like protein 3
classical arabinogalactan protein 9-like
igLON family member 5, transcript variant X3
igLON family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
uncharacterized LOC125061299, transcript variant X1
uncharacterized LOC125061299, transcript variant X3
uncharacterized LOC125061299, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
zinc finger protein ZPR1, transcript variant X1
zinc finger protein ZPR1, transcript variant X2
uncharacterized LOC125061233, transcript variant X1
uncharacterized protein LOC125061233 isoform X1
uncharacterized LOC125061233, transcript variant X2
uncharacterized protein LOC125061233 isoform X2
uncharacterized LOC125061233, transcript variant X4
uncharacterized LOC125061233, transcript variant X3
uncharacterized LOC125061233, transcript variant X5
uncharacterized protein LOC125061233 isoform X3
putative ATP-dependent RNA helicase TDRD12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
putative ATP-dependent RNA helicase TDRD12 isoform X2
putative ATP-dependent RNA helicase TDRD12 isoform X1
putative ATP-dependent RNA helicase TDRD12 isoform X3
uncharacterized LOC125061087, transcript variant X2
uncharacterized LOC125061087, transcript variant X1
protein toll-like, transcript variant X2
protein toll-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial coenzyme A transporter SLC25A42
thioredoxin domain-containing protein 9, transcript variant X1
thioredoxin domain-containing protein 9, transcript variant X2
thioredoxin domain-containing protein 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
uncharacterized LOC125061373, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
uncharacterized LOC125061373, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized protein LOC125061373 isoform X1
uncharacterized protein LOC125061373 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 109 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
exopolyphosphatase PRUNE1, transcript variant X2
exopolyphosphatase PRUNE1, transcript variant X1
suppressor of Mek1-like, transcript variant X1
suppressor of Mek1-like, transcript variant X2
uncharacterized LOC125061363, transcript variant X2
uncharacterized LOC125061363, transcript variant X1
uncharacterized LOC125061363, transcript variant X3
uncharacterized protein LOC125061363 isoform X1
uncharacterized protein LOC125061363 isoform X2
bromodomain-containing protein 8-like, transcript variant X1
bromodomain-containing protein 8-like, transcript variant X2
bromodomain-containing protein 8-like isoform X1
bromodomain-containing protein 8-like isoform X2
uncharacterized LOC125061361, transcript variant X2
uncharacterized LOC125061361, transcript variant X1
uncharacterized protein LOC125061361 isoform X2
uncharacterized protein LOC125061361 isoform X1
uncharacterized LOC125061361, transcript variant X3
uncharacterized protein LOC125061361 isoform X3
phosphatidylserine decarboxylase proenzyme, mitochondrial
zinc finger protein 431-like, transcript variant X1
zinc finger protein 431-like, transcript variant X2
uncharacterized LOC125061378, transcript variant X2
uncharacterized LOC125061378, transcript variant X1
uncharacterized LOC125061378, transcript variant X3
uncharacterized protein LOC125061378 isoform X2
uncharacterized protein LOC125061378 isoform X1
uncharacterized protein LOC125061378 isoform X3
uncharacterized LOC125061366, transcript variant X1
uncharacterized LOC125061366, transcript variant X2
uncharacterized LOC125061366, transcript variant X4
uncharacterized LOC125061366, transcript variant X6
uncharacterized LOC125061366, transcript variant X3
uncharacterized LOC125061366, transcript variant X5
uncharacterized protein LOC125061366 isoform X1
uncharacterized protein LOC125061366 isoform X4
uncharacterized protein LOC125061366 isoform X2
uncharacterized protein LOC125061366 isoform X3
uncharacterized protein LOC125061366 isoform X5
histone-lysine N-methyltransferase PRDM9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM9-like, transcript variant X1
histone-lysine N-methyltransferase PRDM9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 26-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
zinc finger protein 26-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 131 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125061343, transcript variant X2
uncharacterized LOC125061343, transcript variant X1
uncharacterized LOC125061343, transcript variant X4
uncharacterized LOC125061343, transcript variant X3
uncharacterized protein LOC125061343 isoform X2
uncharacterized protein LOC125061343 isoform X1
uncharacterized LOC125061347, transcript variant X2
uncharacterized LOC125061347, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
protein ALP1-like, transcript variant X2
protein ALP1-like, transcript variant X1
uncharacterized protein LOC125061342 isoform X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like isoform X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
zinc finger protein 43-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 43-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 127 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 138 samples with support for all annotated introns
zinc finger protein 813-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
zinc finger protein 813-like, transcript variant X1
uncharacterized protein LOC125061452 isoform X3
zinc finger protein 813-like, transcript variant X2
PR domain zinc finger protein 5-like, transcript variant X1
PR domain zinc finger protein 5-like, transcript variant X2
PR domain zinc finger protein 5-like isoform X2
putative nuclease HARBI1, transcript variant X2
putative nuclease HARBI1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
putative nuclease HARBI1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 131 samples with support for all annotated introns
gamma-tubulin complex component 2-like, transcript variant X2
gamma-tubulin complex component 2-like, transcript variant X1
gamma-tubulin complex component 2-like, transcript variant X3
gamma-tubulin complex component 2-like isoform X3
gamma-tubulin complex component 2-like isoform X2
gamma-tubulin complex component 2-like isoform X1
transient receptor potential cation channel protein painless
single-stranded DNA-binding protein, mitochondrial
uncharacterized LOC125061263, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
uncharacterized LOC125061263, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
uncharacterized LOC125061263, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
uncharacterized protein LOC125061263 isoform X3
uncharacterized protein LOC125061263 isoform X2
uncharacterized protein LOC125061263 isoform X1
DENN domain-containing protein 5B, transcript variant X3
DENN domain-containing protein 5B, transcript variant X2
DENN domain-containing protein 5B, transcript variant X1
DENN domain-containing protein 5B isoform X3
DENN domain-containing protein 5B isoform X2
DENN domain-containing protein 5A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
eye-specific diacylglycerol kinase, transcript variant X1
eye-specific diacylglycerol kinase, transcript variant X4
eye-specific diacylglycerol kinase, transcript variant X3
eye-specific diacylglycerol kinase, transcript variant X2
eye-specific diacylglycerol kinase isoform X1
eye-specific diacylglycerol kinase isoform X2
eye-specific diacylglycerol kinase isoform X4
eye-specific diacylglycerol kinase isoform X3
eye-specific diacylglycerol kinase, transcript variant X5
eye-specific diacylglycerol kinase isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
CRAL-TRIO domain-containing protein C3H8.02, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
CRAL-TRIO domain-containing protein C3H8.02, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
CRAL-TRIO domain-containing protein C3H8.02 isoform X1
CRAL-TRIO domain-containing protein C3H8.02 isoform X2
tyrosine-protein kinase Btk29A, transcript variant X3
tyrosine-protein kinase Btk29A, transcript variant X2
tyrosine-protein kinase Btk29A, transcript variant X1
tyrosine-protein kinase Btk29A, transcript variant X4
tyrosine-protein kinase Btk29A, transcript variant X5
tyrosine-protein kinase Btk29A, transcript variant X6
tyrosine-protein kinase Btk29A isoform X1
tyrosine-protein kinase Btk29A isoform X2
tyrosine-protein kinase Btk29A isoform X3
tyrosine-protein kinase Btk29A isoform X4
mediator of RNA polymerase II transcription subunit 7
uncharacterized LOC125061287, transcript variant X2
uncharacterized LOC125061287, transcript variant X1
uncharacterized LOC125061287, transcript variant X3
homeobox protein CHOX-CAD, transcript variant X1
homeobox protein CHOX-CAD, transcript variant X2
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase-like
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X1
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3 isoform X1
uncharacterized protein LOC125061278 isoform X2
proline-rich extensin-like protein EPR1, transcript variant X2
proline-rich extensin-like protein EPR1, transcript variant X1
proline-rich extensin-like protein EPR1, transcript variant X3
proline-rich extensin-like protein EPR1, transcript variant X5
uncharacterized protein LOC125061264 isoform X1
proline-rich extensin-like protein EPR1 isoform X2
cell surface glycoprotein 1-like isoform X4
proline-rich extensin-like protein EPR1, transcript variant X4
uncharacterized protein LOC125061264 isoform X3
proline-rich extensin-like protein EPR1, transcript variant X6
proline-rich extensin-like protein EPR1 isoform X5
proline-rich extensin-like protein EPR1, transcript variant X7
proline-rich extensin-like protein EPR1 isoform X6
vascular endothelial growth factor receptor 1, transcript variant X2
vascular endothelial growth factor receptor 1, transcript variant X3
vascular endothelial growth factor receptor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
vascular endothelial growth factor receptor 1, transcript variant X1
vascular endothelial growth factor receptor 1, transcript variant X5
vascular endothelial growth factor receptor 1 isoform X1
vascular endothelial growth factor receptor 1 isoform X2
vascular endothelial growth factor receptor 1 isoform X3
vascular endothelial growth factor receptor 1 isoform X5
vascular endothelial growth factor receptor 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
probable cytochrome P450 4d20, transcript variant X1
probable cytochrome P450 4d20, transcript variant X2
probable cytochrome P450 4d20 isoform X2
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit isoform X2
N-acetylglucosamine-6-phosphate deacetylase
transcription factor SPT20 homolog, transcript variant X1
transcription factor SPT20 homolog, transcript variant X3
transcription factor SPT20 homolog, transcript variant X2
transcription factor SPT20 homolog isoform X1
transcription factor SPT20 homolog isoform X3
transcription factor SPT20 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
ufm1-specific protease 2, transcript variant X2
ufm1-specific protease 2, transcript variant X1
zinc transporter 9, transcript variant X2
zinc transporter 9, transcript variant X1
putative uncharacterized protein DDB_G0282133, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 121 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133 isoform X2
putative uncharacterized protein DDB_G0282133, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 158 samples with support for all annotated introns
GATA zinc finger domain-containing protein 7-like isoform X4
putative uncharacterized protein DDB_G0282133 isoform X1
putative uncharacterized protein DDB_G0282133, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 98 samples with support for all annotated introns
pericentriolar material 1 protein-like isoform X3
uncharacterized LOC125061395, transcript variant X2
uncharacterized LOC125061395, transcript variant X1
uncharacterized protein LOC125061395 isoform X2
uncharacterized protein LOC125061395 isoform X1
insulin-like growth factor I, adult form
ras-related and estrogen-regulated growth inhibitor
MAP kinase-activating death domain protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125061474, transcript variant X5
uncharacterized LOC125061474, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125061474, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 110 samples with support for all annotated introns
uncharacterized LOC125061474, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125061474, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC125061474 isoform X3
uncharacterized protein LOC125061474 isoform X1
uncharacterized protein LOC125061474 isoform X2
THO complex subunit 2, transcript variant X2
THO complex subunit 2, transcript variant X1
THO complex subunit 2, transcript variant X3
probable 28S ribosomal protein S6, mitochondrial
translation initiation factor eIF-2B subunit epsilon
anaphase-promoting complex subunit 10, transcript variant X1
anaphase-promoting complex subunit 10, transcript variant X2
anaphase-promoting complex subunit 10 isoform X1
anaphase-promoting complex subunit 10 isoform X2
muscle LIM protein 1-like, transcript variant X2
muscle LIM protein 1-like, transcript variant X1
muscle LIM protein 1-like, transcript variant X4
muscle LIM protein 1-like, transcript variant X5
muscle LIM protein 1-like, transcript variant X3
muscle LIM protein Mlp84B-like isoform X2
muscle LIM protein Mlp84B-like isoform X1
DNA repair protein complementing XP-C cells homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 117 samples with support for all annotated introns
DNA repair protein complementing XP-C cells homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
DNA repair protein complementing XP-C cells homolog isoform X1
DNA repair protein complementing XP-C cells homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 102 samples with support for all annotated introns
ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1
heat shock protein beta-1, transcript variant X2
heat shock protein beta-1, transcript variant X1
heat shock protein beta-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X1
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X1
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X3
uncharacterized LOC125061339, transcript variant X1
uncharacterized LOC125061339, transcript variant X2
uncharacterized protein LOC125061339 isoform X1
uncharacterized protein LOC125061339 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC125061645, transcript variant X2
uncharacterized LOC125061645, transcript variant X1
uncharacterized protein LOC125061645 isoform X1
uncharacterized protein LOC125061645 isoform X2
sterol regulatory element-binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 159 samples with support for all annotated introns
uncharacterized LOC125061571, transcript variant X2
uncharacterized LOC125061571, transcript variant X1
uncharacterized protein LOC125061571 isoform X2
uncharacterized protein LOC125061571 isoform X1
uncharacterized LOC125061572, transcript variant X3
uncharacterized LOC125061572, transcript variant X1
uncharacterized LOC125061572, transcript variant X4
uncharacterized LOC125061572, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC125061572 isoform X2
uncharacterized protein LOC125061572 isoform X4
uncharacterized protein LOC125061572 isoform X3
uncharacterized protein LOC125061572 isoform X1
cilia- and flagella-associated protein 99-like
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like isoform X2
paired box protein Pax-6-like isoform X1
paired box protein Pax-6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
paired box protein Pax-6-like isoform X3
serine/threonine-protein phosphatase rdgC
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 7
chromatin-remodeling complex ATPase chain Iswi
CCR4-NOT transcription complex subunit 7-like, transcript variant X3
CCR4-NOT transcription complex subunit 7-like, transcript variant X2
CCR4-NOT transcription complex subunit 7-like, transcript variant X1
CCR4-NOT transcription complex subunit 7-like isoform X3
CCR4-NOT transcription complex subunit 7-like isoform X2
CCR4-NOT transcription complex subunit 7-like isoform X1
uncharacterized LOC125061399, transcript variant X2
uncharacterized LOC125061399, transcript variant X3
uncharacterized LOC125061399, transcript variant X4
uncharacterized LOC125061399, transcript variant X1
uncharacterized protein LOC125061399 isoform X4
uncharacterized protein LOC125061399 isoform X3
uncharacterized protein LOC125061399 isoform X2
uncharacterized protein LOC125061399 isoform X1
sodium- and chloride-dependent glycine transporter 1-like
probable transaldolase, transcript variant X1
probable transaldolase, transcript variant X2
heat shock 70 kDa protein 4, transcript variant X1
heat shock 70 kDa protein 4, transcript variant X2
39S ribosomal protein L22, mitochondrial
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
uncharacterized LOC125061260, transcript variant X2
uncharacterized LOC125061260, transcript variant X1
28S ribosomal protein S27, mitochondrial
coiled-coil domain-containing protein 22
DEAD-box helicase Dbp80-like, transcript variant X1
DEAD-box helicase Dbp80-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: DEAD-box helicase Dbp80-like
uncharacterized oxidoreductase YrbE-like
delta-sarcoglycan-like, transcript variant X3
delta-sarcoglycan-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
delta-sarcoglycan-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
proton channel OtopLc-like, transcript variant X1
proton channel OtopLc-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proton channel OtopLc-like, transcript variant X3
histone-lysine N-methyltransferase Suv4-20, transcript variant X1
histone-lysine N-methyltransferase Suv4-20, transcript variant X2
histone-lysine N-methyltransferase Suv4-20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125061246, transcript variant X2
uncharacterized LOC125061246, transcript variant X1
uncharacterized LOC125061246, transcript variant X3
uncharacterized protein LOC125061246 isoform X2
uncharacterized protein LOC125061246 isoform X1
uncharacterized protein LOC125061246 isoform X3
succinate dehydrogenase assembly factor 2-A, mitochondrial-like
branched-chain-amino-acid aminotransferase, cytosolic
intraflagellar transport protein 88 homolog
uncharacterized LOC125061191, transcript variant X1
uncharacterized LOC125061191, transcript variant X2
uncharacterized protein LOC125061191 isoform X2
uncharacterized protein LOC125061191 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eukaryotic translation initiation factor 3 subunit M
neurogenic protein mastermind-like, transcript variant X2
neurogenic protein mastermind-like, transcript variant X1
neurogenic protein mastermind-like isoform X2
neurogenic protein mastermind-like isoform X1
heat shock protein 75 kDa, mitochondrial
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X1
putative leucine-rich repeat-containing protein DDB_G0290503, transcript variant X2
putative leucine-rich repeat-containing protein DDB_G0290503 isoform X2
putative leucine-rich repeat-containing protein DDB_G0290503 isoform X1
40S ribosomal protein S10, transcript variant X2
40S ribosomal protein S10, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
zinc transporter 1, transcript variant X2
zinc transporter 1, transcript variant X1
rho-associated protein kinase 1-like, transcript variant X1
rho-associated protein kinase 1-like, transcript variant X3
rho-associated protein kinase 1-like, transcript variant X2
myosin heavy chain, striated muscle-like isoform X1
myosin heavy chain, striated muscle-like isoform X3
rho-associated protein kinase 1-like isoform X2
trichohyalin-like, transcript variant X1
trichohyalin-like, transcript variant X4
trichohyalin-like, transcript variant X2
trichohyalin-like, transcript variant X5
trichohyalin-like, transcript variant X3
ribosome-binding protein 1-like isoform X2
protein lava lamp-like, transcript variant X1
protein lava lamp-like, transcript variant X2
39S ribosomal protein L28, mitochondrial
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X3
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 115 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X2
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 157 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 152 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit alpha isoform X3
probable phosphorylase b kinase regulatory subunit alpha isoform X6
probable phosphorylase b kinase regulatory subunit alpha isoform X5
probable phosphorylase b kinase regulatory subunit alpha isoform X1
probable phosphorylase b kinase regulatory subunit alpha isoform X7
probable phosphorylase b kinase regulatory subunit alpha isoform X4
probable phosphorylase b kinase regulatory subunit alpha isoform X2
adenylate cyclase type 9, transcript variant X2
adenylate cyclase type 9, transcript variant X1
gamma-aminobutyric acid receptor alpha-like
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-like isoform X1
gamma-aminobutyric acid receptor subunit beta-like isoform X2
low-density lipoprotein receptor-related protein 4-like